The stock price of ambulatory software vendor Greenway Medical Technologies fell almost 23 percent on April 29 then immediately gained 4 percent in after-hours trading after the company significantly downgraded its financial performance for the rest of fiscal 2013, which ends on June 30.

Greenway will report third quarter results on May 6, but based on preliminary results issued a profit warning for the quarter. The company expects quarterly revenue of $132 million to $134 million, compared with a previous consensus of investment analysts’ expectations of about $146.7 million. The vendor expects a net income loss of 11 to 13 cents per share in the third quarter; analysts had expected 10 to 17 cents of profit, according to The Motley Fool.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access